ALD patients with severe liver dysfunction, classified as CTP class C, MELD-Na ≥ 20, and MELD 3.0 > 19, presented with significantly higher levels of CXCL9 and CXCL10, but CXCL16 concentrations did not differ significantly in these subgroups. Here, CXCL9 is linked to Decreased liver function.